Suppr超能文献

真武汤通过激活肾小管 NRF2 和 TFAM 为线粒体生物能提供燃料来抑制肾纤维化。

Zhen Wu decoction represses renal fibrosis by invigorating tubular NRF2 and TFAM to fuel mitochondrial bioenergetics.

机构信息

Department of Pharmacy, Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Department of Kidney Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

出版信息

Phytomedicine. 2023 Jan;108:154495. doi: 10.1016/j.phymed.2022.154495. Epub 2022 Oct 8.

Abstract

BACKGROUND

Zhen Wu Decoction (ZWD) is a prescription from the classical text "Treatise on Exogenous Febrile Disease" and has been extensively used to control kidney diseases since the time of the Eastern Han Dynasty.

HYPOTHESIS

We hypothesized that ZWD limits tubular fibrogenesis by reinvigorating tubular bio-energetic capacity.

STUDY DESIGN / METHODS: A mouse model of chronic kidney disease (CKD) was established using unilateral ureteral obstruction (UUO). Three concentrations of ZWD, namely 25.2 g/kg (high dosage), 12.6 g/kg (middle dosage), and 6.3 g/kg (low dosage), were included to study the dose-effect relationship. Real-time qPCR was used to observe gene transcription in blood samples from patients with CKD. Different siRNAs were designed to study the role of mitochondrial transcription factor A (TFAM) and nuclear factor (erythroid-derived 2)-related factor 2 (NRF2) in transforming growth factor (TGF)-β1 induced fibrogenesis and mitochondrial damage.

RESULTS

We showed that ZWD efficiently attenuates renal function impairment and reduces renal interstitial fibrosis. TFAM and NRF2 were repressed, and the stimulator of interferon genes (STING) was activated in CKD patient blood sample. We further confirmed that ZWD activated TFAM depended on NRF2 as an important negative regulator of STING in mouse kidneys. Treatment with ZWD significantly reduced oxidative stress and inflammation by regulating the levels of oxidative phosphorylation (OXPHOS) and pro-inflammatory factors, such as interleukin-6, interleukin-1β, tumor necrosis factor receptor 1, and mitochondrial respiratory chain subunits. NRF2 inhibitors can weaken the ability of ZWD to increase TFAM expression and heal injured mitochondria, playing a similar role to that of STING inhibitors. Our study showed that ZWD elevates the expression of TFAM and mitochondrial respiratory chain subunits by promoting NRF2 activation, after suppressing mitochondrial membrane damage and cristae breakdown and restricting mitochondrial DNA (mtDNA) leakage into the cytoplasm to reduce STING activation.

CONCLUSION

ZWD maintains mitochondrial integrity and improves OXPHOS which represents an innovative insight into "strengthening Yang-Qi" theory. ZWD limits tubular fibrogenesis by reinvigorating tubular bioenergetic capacity.

摘要

背景

真武汤(ZWD)是经典著作《伤寒论》中的方剂,自东汉以来,已广泛用于控制肾脏疾病。

假说

我们假设 ZWD 通过恢复肾小管生物能量能力来限制肾小管纤维发生。

研究设计/方法:使用单侧输尿管梗阻(UUO)建立慢性肾脏病(CKD)小鼠模型。包括三种浓度的 ZWD,即 25.2g/kg(高剂量)、12.6g/kg(中剂量)和 6.3g/kg(低剂量),以研究剂量效应关系。实时 qPCR 用于观察 CKD 患者血液样本中的基因转录。设计了不同的 siRNA 来研究线粒体转录因子 A(TFAM)和核因子(红系衍生 2)相关因子 2(NRF2)在转化生长因子(TGF)-β1 诱导的纤维化和线粒体损伤中的作用。

结果

我们表明 ZWD 可有效减轻肾功能损害并减少肾间质纤维化。TFAM 和 NRF2 受到抑制,CKD 患者血液样本中的干扰素基因刺激物(STING)被激活。我们进一步证实,ZWD 通过作为小鼠肾脏中 STING 的重要负调节剂来激活 TFAM 依赖于 NRF2。ZWD 治疗通过调节氧化磷酸化(OXPHOS)和促炎因子(如白细胞介素 6、白细胞介素 1β、肿瘤坏死因子受体 1 和线粒体呼吸链亚基)的水平,显著减轻氧化应激和炎症。NRF2 抑制剂可削弱 ZWD 增加 TFAM 表达和修复受损线粒体的能力,其作用类似于 STING 抑制剂。我们的研究表明,ZWD 通过促进 NRF2 激活来提高 TFAM 和线粒体呼吸链亚基的表达,抑制线粒体膜损伤和嵴破裂,并限制线粒体 DNA(mtDNA)漏入细胞质以减少 STING 激活。

结论

ZWD 通过恢复肾小管生物能量能力来维持线粒体完整性和改善 OXPHOS,这代表了对“补气”理论的创新见解。ZWD 通过恢复肾小管生物能量能力来限制肾小管纤维发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验